The results in Lancet were insufficient to convince the sponsor of the trial/open label that I have been involved with, so as of February 23, I will no longer be using LMTM as I have no way of getting the drug anymore,
I had experienced some decline recently; short term memory is much worse, some disorientation. It is not yet debilitating and with the help of my sweetheart and friends, I am doing OK. I am still on Donepezil and Namenda, and am looking for other tau therapy trials. (Why the industry is still pushing amyloid is beyond me or my neurologist's understanding.)
